EPRS expression was associated with reduced overall survival in patients with ER+, but not ER- breast cancers and was associated with reduced distant relapse-free survival in patients treated with tamoxifen adjuvant monotherapy. The gene discussed is ESR1; the disease is breast carcinoma.